Journal
MOLECULAR ENDOCRINOLOGY
Volume 22, Issue 6, Pages 1394-1402Publisher
OXFORD UNIV PRESS INC
DOI: 10.1210/me.2007-0525
Keywords
-
Categories
Funding
- NHLBI NIH HHS [R01 HL066088-10, R01 HL066088] Funding Source: Medline
Ask authors/readers for more resources
Macrophages are phagocytic cells that play essential roles in innate immunity and lipid homeostasis. The uptake of modified lipoproteins is an important early event in the development of atherosclerosis. We analyzed the ability of modified low-density lipoprotein (LDL) (oxidized and acetylated) to alter the expression and activity of arginases (ArgI and ArgII) in macrophages. We show that ArgI expression is potently induced by both oxidized and acetylated LDL in macrophages. We further show that this effect is mediated by peroxisome proliferator-activated receptors (PPAR). ArgI expression is highly responsive to agonists for PPAR gamma and PPAR delta but not PPAR alpha. Moreover, the induction of ArgI by both PPAR agonists and IL-4 is blocked in macrophages from PPAR gamma- and PPAR delta-deficient mice. Functionally, PPAR activity induces macrophage activation toward a more Th2 immune phenotype in a model of Leishmania major infection. We show that PPAR gamma and -delta ligands promote intracellular amastigote growth in infected macrophages, and this effect is dependent on both PPAR expression and Arg activity. Collectively, our results strongly suggest that ArgI is a key marker of the alternative program triggered by PPAR in macrophages.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available